Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,134
Closed -$244K 74
2023
Q2
$244K Sell
2,134
-1
-0% -$99 0.11% 67
2023
Q1
$242K Sell
2,135
-1
-0% -$169 0.12% 68
2022
Q4
$382K Sell
2,136
-625
-23% -$150K 0.22% 59
2022
Q3
$737K Sell
2,761
-745
-21% -$191K 0.44% 50
2022
Q2
$502K Sell
3,506
-15
-0.4% -$2.49K 0.27% 63
2022
Q1
$775K Buy
3,521
+1,471
+72% +$342K 0.3% 64
2021
Q4
$778K Buy
+2,050
New +$888K 0.28% 66

Other funds holding STEM

Altrafin AG's STEM Position: Q3 2023 in Review

Altrafin AG sold out of Stem (STEM) in Q3 2023, closing a stake of 2,134 shares — an estimated $244K sold.

Altrafin AG first reported a position in STEM in Q4 2021 and held it in 7 quarters. The position peaked at $778K in Q4 2021. 224 funds tracked by Wall St. Rank hold STEM as of Q3 2023.

  • Altrafin AG reported no remaining Stem position as of Q3 2023 after selling out during the quarter.
  • Altrafin AG sold 2,134 Stem shares in Q3 2023, an estimated $244K.
  • Altrafin AG first reported a position in Stem in Q4 2021 and held it in 7 quarters.
  • Altrafin AG's Stem position peaked at $778K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Stem as of Q3 2023.

Based on Altrafin AG's 13F filing for Q3 2023, filed 17 Feb 2026.